E-LIB Suche - Ergebnisse für: Bon, Giulia

1

Role of Hippo pathway dysregulation from gastrointestinal p..:

Schiavoni, Giulia ; Messina, Beatrice ; Scalera, Stefano...
Journal of Translational Medicine. 22 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

2

Correction to: Role of Hippo pathway dysregulation from gas..:

Schiavoni, Giulia ; Messina, Beatrice ; Scalera, Stefano...
Journal of Translational Medicine. 22 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

HER2 mutation as an emerging target in advanced breast canc..:

Bon, Giulia ; Di Lisa, Francesca Sofia ; Filomeno, Lorena...
Cancer Science. , 2024

Link: https://doi.org/10.1111/..

4

DARPP-32 and t-DARPP in the development of resistance to an..:

Bon, Giulia ; Krasniqi, Eriseld ; Porru, Manuela...
Neoplasia. 45 (2023) - p. 100937 , 2023

Link: https://doi.org/10.1016/..

5

Hippo pathway dysregulation in gastric cancer: from Helicob..:

Messina, Beatrice ; Lo Sardo, Federica ; Scalera, Stefano...
Cell Death & Disease. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

6

Corrigendum: Cross-resistance among sequential cancer thera..:

Loria, Rossella ; Vici, Patrizia ; Di Lisa, Francesca Sofia...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

7

SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and..:

Loria, Rossella ; Laquintana, Valentina ; Scalera, Stefano...
Journal of Experimental & Clinical Cancer Research. 41 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

8

Cross-Resistance Among Sequential Cancer Therapeutics: An E..:

Loria, Rossella ; Vici, Patrizia ; Di Lisa, Francesca Sofia...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

9

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive ..:

Bon, Giulia ; Pizzuti, Laura ; Laquintana, Valentina...
Journal of Experimental & Clinical Cancer Research. 39 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

10

HMGA1/E2F1 axis and NFkB pathways regulate LPS progression ..:

Loria, Rossella ; Laquintana, Valentina ; Bon, Giulia...
Oncogene. 37 (2018) 45 - p. 5926-5938 , 2018

Link: https://doi.org/10.1038/..

11

Dual targeting of HER3 and MEK may overcome HER3-dependent ..:

Bon, Giulia ; Loria, Rossella ; Amoreo, Carla Azzurra...
Oncotarget. 8 (2016) 65 - p. 108463-108479 , 2016

Link: https://doi.org/10.18632..

12

Sema6A and Mical1 control cell growth and survival of BRAFV..:

Loria, Rossella ; Bon, Giulia ; Perotti, Valentina...
Oncotarget. 6 (2014) 5 - p. 2779-2793 , 2014

Link: https://doi.org/10.18632..

13

miR-221/222 control luminal breast cancer tumor progression..:

Dentelli, Patrizia ; Traversa, Matteo ; Rosso, Arturo...
Cell Cycle. 13 (2014) 11 - p. 1811-1826 , 2014

Link: https://doi.org/10.4161/..

14

CBX7 gene expression plays a negative role in adipocyte cel..:

Forzati, Floriana ; Federico, Antonella ; Pallante, Pierlorenzo...
Biology Open. 3 (2014) 9 - p. 871-879 , 2014

Link: https://doi.org/10.1242/..

15

Purification and Characterization of Adipose-Derived Stem C..:

Folgiero, Valentina ; Migliano, Emilia ; Tedesco, Marinella...
Cell Medicine. 1 (2010) 1 - p. 3-14 , 2010

Link: https://doi.org/10.3727/..